Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Strictosidinic acid

Catalog No. TN2240 Copy Product Info
🥰Excellent
Strictosidinic acid is a glycosylated indole monoterpene alkaloid isolated from the leaves of Psychotria myriantha. Strictosidinic acid exhibits oral bioactivity, inhibiting the precursor enzymes involved in 5-HT biosynthesis and reducing 5-HT levels. Strictosidinic acid possesses analgesic and antipyretic activity.

Strictosidinic acid

Copy Product Info
🥰Excellent
Catalog No. TN2240

Strictosidinic acid is a glycosylated indole monoterpene alkaloid isolated from the leaves of Psychotria myriantha. Strictosidinic acid exhibits oral bioactivity, inhibiting the precursor enzymes involved in 5-HT biosynthesis and reducing 5-HT levels. Strictosidinic acid possesses analgesic and antipyretic activity.

Strictosidinic acid
Cas No. 150148-81-5
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$415-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Strictosidinic acid is a glycosylated indole monoterpene alkaloid isolated from the leaves of Psychotria myriantha. Strictosidinic acid exhibits oral bioactivity, inhibiting the precursor enzymes involved in 5-HT biosynthesis and reducing 5-HT levels. Strictosidinic acid possesses analgesic and antipyretic activity.
In vitro
Methods: Rat brain mitochondria were preincubated with different concentrations of strictosidinic acid (0.1–500 μg/mL) at 37°C for 30 minutes, and the inhibition rates of MAO-A and MAO-B activity were measured using a fluorescence assay.
Results: Strictosidinic acid inhibited MAO-A activity in a concentration-dependent manner, with an IC₅₀ of 150.1 ± 1.25 μg/mL and a maximum inhibition rate of 68.67%. [1]
In vivo
Methods: Male Wistar rats were administered Strictosidinic acid (10 mg/kg) via intraperitoneal injection. They were euthanized 60 minutes after administration, and hippocampal tissue was harvested.
Results: Compared with the control group, the Strictosidinic acid-treated group showed a 63.4% decrease in 5-HT levels and a 67.4% decrease in DOPAC levels in the hippocampus.[1]
Chemical Properties
Molecular Weight516.54
FormulaC26H32N2O9
Cas No.150148-81-5
SmilesC([C@H]1C2=C(C=3C(N2)=CC=CC3)CCN1)[C@H]4[C@@H](C=C)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)OC=C4C(O)=O
Relative Density.1.50 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Strictosidinic acid | purchase Strictosidinic acid | Strictosidinic acid cost | order Strictosidinic acid | Strictosidinic acid chemical structure | Strictosidinic acid in vivo | Strictosidinic acid in vitro | Strictosidinic acid formula | Strictosidinic acid molecular weight